Valuation: Nexstim Oyj

Market Cap 76.63M 87.37M 70.97M 65.3M 124M 8.36B 126M 846M 332M 4.11B 328M 321M 14.18B P/E 2026 *
79.1x
P/E 2027 * 35.1x
Enterprise Value 74.53M 84.97M 69.03M 63.51M 120M 8.13B 122M 823M 323M 3.99B 319M 312M 13.79B EV / Sales 2026 *
5.87x
EV / Sales 2027 * 4.53x
Free-Float
58.2%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 2020-02-10
Director of Finance/CFO 40 2020-02-10
Chief Tech/Sci/R&D Officer 65 2007-12-31
Director TitleAgeSince
Director/Board Member 64 2019-11-10
Chairman 63 2019-11-10
Director/Board Member 55 2021-04-30
Change 5-day change 1-year change 3-year change Capi.($)
-6.90%-5.73% - - 87.37M
+0.28%+2.11%+21.54%+0.35% 196B
+0.08%-5.94%-20.49%+17.34% 144B
+0.56%+3.38%-2.29%-16.18% 142B
-0.27%+0.11%-56.73%-15.42% 66.37B
-0.46%-3.56%+17.60%-1.40% 52.85B
-0.80%-0.17%-23.48%-31.91% 45.22B
-0.19%+2.63%+8.73%+12.31% 37.86B
-0.85%-1.50%+5.76%+38.61% 36.64B
+0.94%+0.72%-13.07%-19.77% 29.71B
Average -0.78%-0.09%-6.94%-1.79% 83.43B
Weighted average by Cap. +0.06%-0.32%-3.72%-1.29%

Financials

2026 *2027 *
Net sales 12.7M 14.48M 11.76M 10.82M 20.47M 1.39B 20.87M 140M 54.98M 681M 54.37M 53.18M 2.35B 16.1M 18.36M 14.91M 13.72M 25.95M 1.76B 26.46M 178M 69.7M 863M 68.93M 67.42M 2.98B
Net income 1M 1.14M 926K 852K 1.61M 109M 1.64M 11.04M 4.33M 53.59M 4.28M 4.19M 185M 2.2M 2.51M 2.04M 1.87M 3.55M 240M 3.62M 24.29M 9.52M 118M 9.42M 9.21M 407M
Net Debt -2.1M -2.39M -1.94M -1.79M -3.38M -229M -3.45M -23.18M -9.09M -113M -8.99M -8.79M -389M -3.7M -4.22M -3.43M -3.15M -5.96M -404M -6.08M -40.84M -16.02M -198M -15.84M -15.49M -685M
Logo Nexstim Oyj
Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-